Back
Candel Therapeutics Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
59
CADL
Candel Therapeutics
Last Price:
$8.74
Seasonality Move:
-11.47%
Sell
40
BMY
Bristol-Myers Squibb
Last Price:
$57.30
Seasonality Move:
1.66%
Buy
59
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy, Sell or Hold?
-
The current Candel Therapeutics [CADL] share price is $8.75. The Score for CADL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CADL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
-
The current Bristol-Myers Squibb [BMY] share price is $57.33. The Score for BMY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CADL Stock Price Chart
What is Candel Therapeutics's stock price today?
-
The Candel Therapeutics share price today is $8.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $57.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CADL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.87 | Buy |
Relative Strength Index (14 RSI): | 61.32 | Buy |
Chaikin Money Flow: | -2064192 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.83 - 7.33) | Buy |
Bollinger Bands (100): | (4.74 - 6.98) | Buy |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 51.02 | Buy |
Chaikin Money Flow: | 45046909 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.68 - 59.08) | Sell |
Bollinger Bands (100): | (48.85 - 56.81) | Buy |
CADL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.79 | Buy |
20-day SMA: | 5.98 | Buy |
50-day SMA: | 5.49 | Buy |
200-day SMA: | 6.1 | Buy |
8-day EMA: | 7.58 | Buy |
20-day EMA: | 6.46 | Buy |
50-day EMA: | 5.89 | Buy |
200-day EMA: | 5.41 | Buy |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.59 | Buy |
20-day SMA: | 57.98 | Sell |
50-day SMA: | 56.11 | Buy |
200-day SMA: | 49.22 | Buy |
8-day EMA: | 57.01 | Buy |
20-day EMA: | 57.29 | Buy |
50-day EMA: | 55.96 | Buy |
200-day EMA: | 52.03 | Buy |
Candel Therapeutics Earnings Growth & CADL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.03 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.17 per share.
Candel Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |